LPL Financial
MRNA icon

LPL Financial’s Moderna MRNA Stock Holding History

LPL Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Sell
162,378
-15,662
-9% -$810K ﹤0.01% 2017
2026
Q1 		$9.04M Sell
178,040
-46,119
-21% -$2.15M ﹤0.01% 2071
2025
Q4 		$6.61M Sell
224,159
-14
-0% -$380 ﹤0.01% 2295
2025
Q3 		$5.79M Buy
224,173
+39,010
+21% +$1.09M ﹤0.01% 2338
2025
Q2 		$5.11M Sell
185,163
-491,049
-73% -$12.9M ﹤0.01% 2289
2025
Q1 		$19.2M Buy
676,212
+308,334
+84% +$10.9M 0.01% 1173
2024
Q4 		$15.3M Buy
367,878
+265,982
+261% +$12.7M 0.01% 1239
2024
Q3 		$6.81M Sell
101,896
-10,217
-9% -$938K ﹤0.01% 1749
2024
Q2 		$13.3M Buy
112,113
+7,998
+8% +$1.01M 0.01% 1187
2024
Q1 		$11.1M Buy
104,115
+11,595
+13% +$1.17M 0.01% 1265
2023
Q4 		$9.2M Sell
92,520
-23,262
-20% -$1.96M 0.01% 1305
2023
Q3 		$12M Buy
115,782
+7,811
+7% +$871K 0.01% 1058
2023
Q2 		$13.1M Buy
107,971
+10,239
+10% +$1.37M 0.01% 991
2023
Q1 		$15M Sell
97,732
-3,614
-4% -$596K 0.01% 887
2022
Q4 		$18.2M Buy
101,346
+4,430
+5% +$724K 0.02% 747
2022
Q3 		$11.5M Sell
96,916
-7,390
-7% -$1.12M 0.01% 889
2022
Q2 		$14.9M Sell
104,306
-838
-0.8% -$120K 0.01% 764
2022
Q1 		$18.1M Sell
105,144
-15,053
-13% -$2.53M 0.02% 709
2021
Q4 		$30.5M Sell
120,197
-29,864
-20% -$8.73M 0.03% 506
2021
Q3 		$57.8M Buy
150,061
+24,239
+19% +$8.94M 0.05% 316
2021
Q2 		$29.6M Buy
125,822
+10,712
+9% +$1.91M 0.03% 455
2021
Q1 		$15.1M Sell
115,110
-9,358
-8% -$1.36M 0.02% 646
2020
Q4 		$13M Sell
124,468
-15,733
-11% -$1.59M 0.02% 626
2020
Q3 		$9.92M Buy
140,201
+60,120
+75% +$4.19M 0.02% 649
2020
Q2 		$5.14M Buy
80,081
+22,327
+39% +$1.22M 0.01% 864
2020
Q1 		$1.73M Buy
+57,754
New +$1.33M ﹤0.01% 1285

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

LPL Financial's MRNA Position: Q2 2026 in Review

LPL Financial reduced its Moderna (MRNA) stake by 8.8% in Q2 2026, selling an estimated $810K and leaving 162,378 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2017.

LPL Financial first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $57.8M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • LPL Financial held 162,378 shares of Moderna worth $11.4M as of Q2 2026.
  • LPL Financial sold 15,662 Moderna shares in Q2 2026, an estimated $810K.
  • Moderna made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2017 holding.
  • LPL Financial first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • LPL Financial's Moderna position peaked at $57.8M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.